Clinical trials: Scleroderma Renal Crisis
Scleroderma Renal Crisis
Effect of Bosentan in Scleroderma Renal Crisis
Systemic sclerosis (SSc) is a connective tissue disease characterized by excessive collagen deposition, autoimmunity and by vascular hyper-reactivity and obliterative microvascular phenomena that involves multiple organs.
- Trial name
- ScS-REINBO (NCT01241383)
- Testing
- Bosentan
- Where
- France
- Volunteers
- 16 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Scleroderma, Scleroderma Renal Crisis
Zibotentan Better Renal Scleroderma Outcome Study
Many patients with scleroderma have damage to their kidneys caused by the disease. There is limited evidence for treatments to prevent this damage or stop it progressing.
- Conditions
- Scleroderma, Scleroderma Renal Crisis, Chronic Kidney Disease
- Trial name
- ZEBRA (NCT02047708)
- Testing
- Zibotentan
- Where
- United Kingdom
- Volunteers
- 27 people
- Sponsor
- University College, London